ADDRESSES AND ORIGINAL ARTICLESPAROXYSMAL NOCTURNAL HÆMOGLOBINURIA OF THE MARCHIAFAVA TYPE
References (42)
- et al.
Lancet
(1922) - et al.
Lancet
(1924) Lancet
(1936)- et al.
Virchows Arch.
(1929) Acta med. scand.
(1931)Rif. med.
(1915)- et al.
Quart. J. Med.
(1938) - et al.
Bull. Soc. méd. Hôp. Paris
(1937) - et al.
Bull. Soc. méd. Hôp. Paris
(1908) - et al.
Sem. méd., Paris
(1909)
Ueber das Wesen der paroxysmalen Hämoglobinurie
(1894)
J. Path. Bact.
(1938)
Münch. med. Wschr.
(1902)
Klin. Wschr.
(1928)
Klin. Wschr.
(1935)
Arch. intern. Med.
(1923)
Dtsch. med. Wschr.
(1911)
Amer. J. med. Sci.
(1936)
Wien. med. Wschr.
(1930)
Klin. Wschr.
(1934)
Cited by (17)
New dawn for a nocturnal disease
2005, BloodGlycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria
2000, Critical Reviews in Oncology/HematologyParoxysmal nocturnal hemoglobinuria (PNH): Mechanism of intravascular hemolysis
1996, Critical Reviews in Oncology/HematologyEculizumab treatment: Stochastic occurrence of C3 binding to individual PNH erythrocytes
2017, Journal of Hematology and OncologySir John Dacie MD, FRS, FRCP, FRCPath
2005, British Journal of HaematologyHaematology at the Hammersmith Hospital and Royal Postgraduate Medical School 1934-1994
2003, British Journal of Haematology
Copyright © 1938 Published by Elsevier Ltd.